Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study

NACompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

July 31, 2012

Conditions
Heart Failure
Interventions
DEVICE

CRT-D and LV lead (Quartet™ lead and Promote Q® device system)

Promote Q CRT-D and Quartet LV lead

Trial Locations (24)

10029

Mount Sinai Hospital, New York

17602

Lancaster Heart Foundation, Lancaster

30309

Piedmont Hospital, Atlanta

32806

Orlando Heart Center, Orlando

33705

The Heart and Vascular Institute of Florida - S. Pinellas, St. Petersburg

35233

University Hospital of Alabama at Birmingham, Birmingham

37205

St. Thomas Hospital, Nashville

38104

Methodist University Hospital, Memphis

40503

Central Baptist Hospital, Lexington

44035

EMH Regional Medical Center, Elyria

44195

The Cleveland Clinic Foundation, Cleveland

48910

Thoracic Cardiovascular Healthcare Foundation, Lansing

53215

Arrhythmia Center for Southern Wisconsin, Milwaukee

60148

Midwest Heart Foundation, Lombard

72205

Baptist Health Medical Center, Little Rock

72211

Arkansas Heart Hospital, Little Rock

90033

University of Southern California, Los Angeles

91204

Glendale Memorial Medical Center, Glendale

92037

Scripps Green Hospital, San Diego

94040

ACS Research Group, Mountain View

95819

Regional Cardiology Associates, Sacramento

01805

Lahey Clinical Medical Center, Burlington

08015

Deborah Heart and Lung Center, Browns Mills

07962

Morristown Memorial Hospital, Morristown

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY